| Trial ID: | L4507 |
| Source ID: | NCT01040819
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01040819/results
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Pioglitazone
|
| Outcome Measures: |
Primary: Plasma 15-epi-lipoxin A4, Plasma 15-epi-LXA4 levels, 2 months |
|
| Sponsor/Collaborators: |
Sponsor: Baylor College of Medicine
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
25
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-02
|
| Completion Date: |
2011-12
|
| Results First Posted: |
2016-06-22
|
| Last Update Posted: |
2016-06-22
|
| Locations: |
Baylor Clinics, Houston, Texas, 77030, United States|Baylor College of Medicine, HOuston, Texas, 77030, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01040819
|
